Philip Empey
Overview
Explore the profile of Philip Empey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LeCompte K, Coons J, Empey P, Berenbrok L
Curr Pharm Teach Learn
. 2024 Dec;
17(3):102189.
PMID: 39729765
No abstract available.
2.
Luvsantseren S, Whirl-Carrillo M, Sangkuhl K, Shin N, Wen A, Empey P, et al.
J Pers Med
. 2020 Nov;
10(4).
PMID: 33142667
In the current marketplace, there are now more than a dozen commercial companies providing pharmacogenetic tests. Each company varies in the panel of genes they test and the variants they...
3.
Johnson A, Broughton S, Aponte-Soto L, Watson K, Pinto C, Empey P, et al.
Ethn Dis
. 2020 Apr;
30(Suppl 1):167-176.
PMID: 32269458
Objective: We assessed feasibility of an educational program designed to enhance stakeholder knowledge and perceptions of pharmacogenomics at a federally qualified health center (FQHC). Design: FQHCs have a rich history...
4.
Kogan J, Empey P, Kanter J, Keyser D, Shrank W
Am J Manag Care
. 2018 Apr;
24(4):177-179.
PMID: 29668207
A long-held assumption and expectation has been that genomics-based precision medicine will provide clinicians with the tools and therapies they need to consistently deliver the right treatment to the right...
5.
Kochanek P, Bramlett H, Dixon C, Dietrich W, Mondello S, Wang K, et al.
Mil Med
. 2018 Apr;
183(suppl_1):303-312.
PMID: 29635589
Operation brain trauma therapy (OBTT) is a multi-center, pre-clinical drug and biomarker screening consortium for traumatic brain injury (TBI). Therapies are screened across three rat models (parasagittal fluid percussion injury,...
6.
Benedict N, Smithburger P, Donihi A, Empey P, Kobulinsky L, Seybert A, et al.
Am J Pharm Educ
. 2017 Mar;
81(1):14.
PMID: 28289304
To design an assessment of practice readiness using blended-simulation progress testing. A five-station, blended simulation assessment was developed to evaluate patient care outcomes in first- and third-year pharmacy (P1 and...
7.
Romagnoli K, Nelson S, Hines L, Empey P, Boyce R, Hochheiser H
BMC Med Inform Decis Mak
. 2017 Feb;
17(1):21.
PMID: 28228132
Background: Drug information compendia and drug-drug interaction information databases are critical resources for clinicians and pharmacists working to avoid adverse events due to exposure to potential drug-drug interactions (PDDIs). Our...
8.
Margulies S, Anderson G, Atif F, Badaut J, Clark R, Empey P, et al.
J Neurotrauma
. 2015 May;
33(1):101-12.
PMID: 25970337
Patients enrolled in clinical trials for traumatic brain injury (TBI) may present with heterogeneous features over a range of injury severity, such as diffuse axonal injury, ischemia, edema, hemorrhage, oxidative...
9.
Hatton J, Rosbolt B, Empey P, Kryscio R, Young B
J Neurosurg
. 2008 Oct;
109(4):699-707.
PMID: 18826358
Object: Cyclosporine neuroprotection has been reported in brain injury models but safety and dosing guidelines have not been determined in humans with severe traumatic brain injury (TBI). The purpose of...